The emerging role of leukotriene antagonists in asthma therapy

Chest

Volumn 115, Issue 2, 1999, Pages 313-316

  Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; MONTELUKAST; SALMETEROL; ZAFIRLUKAST; ZILEUTON;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; DRUG SAFETY; EDITORIAL; HUMAN; ICOSANOID METABOLISM; LIVER TOXICITY; PRIORITY JOURNAL;

EID: 0032909449     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.2.313     Document Type: Editorial

References (28)

1. PM O'Byrne Leukotrienes in the pathogenesis of asthma Chest 111 1997 27S 34S
2. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma J Allergy Clin Immunol 90 1992 32 42
3. PJ Barnes S Pedersen WW Busse Efficacy and safety of inhaled corticosteroids: new developments Am J Respir Crit Care Med 157 pt 2 1998 S1 S53
4. National Asthma Education and Prevention Program. Expert panel report II: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1997; publication 97-4051
5. AH Jones CG Langdon PS Lee Pulmicort turbuhaler once daily as initial prophylactic therapy for asthma Respir Med 88 1994 293 299
6. JE Fish JP Kemp RF Lockey Zafirlukast for symptomatic mild to moderate asthma, a 13 week multicentre study Clin Ther 19 1997 675 690
7. S Suissa R Dennis P Ernst Effectiveness of the leukotriene receptor antagonist zafirlukast for mild to moderate asthma: a randomized, double-blind, placebo control trial Am Intern Med 126 1997 177 183
8. B Knorr J Matz JA Bernstein Montelukast for chronic asthma in 6 to 14 year old children JAMA 279 1998 1181 1186
9. TF Reiss P Chervinisky RJ Dockhorn Montelukast, a once daily leukotriene receptor antagonist in the treatment of chronic asthma: a multicentre, randomized double-blind trial Arch Intern Med 158 1998 1213 1220
10. Data on file. Merck Sharp and Dohme Limited, UK. Singulair product data sheet, 1998
11. AS Nayak P Anderson BL Charous Equivalence of adding zafirlukast versus double-dose inhaled corticosteroids in asthmatic patients symptomatic on low-dose inhaled corticosteroids J Allergy Clin Immunol 101 pt 2 1998 S233
12. JA Leff E Israel NJ Noonan Montelukast allows tapering of inhaled corticosteroids in asthmatic patients whilst maintaining clinical stability Am J Respir Crit Care Med 155 pt 2 1997 A976
13. 4excretion Am Rev Respir Dis 147 1993 142 146
14. R Dworski GA Fitzgerald JA Oats Effect of oral prednisone on airway inflammatory mediators in atopic asthma Am J Respir Crit Care Med 149 1994 953 959
15. CA Riddick LL Ring JR Baker Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells Eur J Biochem 246 1997 112 118
16. JA Leff E Pizzichini A Efthimiadis Effect of montelukast on airway eosinphilic inflammation in mildly uncontrolled asthma: a randomized placebo controlled trial Am J Repir Crit Care Med 155 pt 2 1997 A977
17. WJ Calhoun B Lavins MC Minkwitz Effect of zafirlukcast (accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge Am J Repir Crit Care Med 157 1998 138 139
18. R Pauwels CG Lofdahl D Postma Effect of inhaled formoterol and budesonide on exacerbations of asthma N Engl J Med 337 1997 1405 1411
19. BJ Lipworth Airway subsensitivity with long-acting beta 2-agonists: is there cause for concern? Drug Safety 16 1997 295 308
20. L Ramage BJ Lipworth CG Ingram Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol Respir Med 88 1994 363 368
21. B Lipworth S Tan M Devlin Effects of treatment with formoterol on bronchoprotection against methacholine Am J Med 104 1998 431 438
22. JA Turpin JM Edelman PT DeLucca Chronic administration of montelukast is superior to inhaled salmeterol in the prevention of exercise-induced bronchoconstriction Am J Respir Crit Care Med 157 pt 2 1998 A456
23. P Gardiner C Ward H Booth Effect of 8 weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics Am J Respir Crit Care Med 150 1994 1006 1011
24. E Pizzichini RA McIvor MO Turner Masking effect of salmeterol in exacerbations of asthma induced by steroid reduction: a randomised controlled trial Eur Respir J 10 suppl 25 1997 1s
25. K Malmstrom E Meltzer B Prenner Effects of montelukast (a leukotriene receptor antagonist), loratidine, montelukast + loratidine and placebo in seasonal allergic rhinitis and conjunctivitis J Allergy Clin Immunol 101 pt 2 1998 S97
26. DJ Evans DA Taylor O Zetterstrom A comparison of low dose inhaled budesonide plus theophylline and high dose inhaled budesonide for moderate asthma N Engl J Med 337 1997 1412 1418
27. J Kidney M Dominguez PM Taylor Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy Am J Respir Crit Care Med 151 1995 1907 1914
28. KH In K Asano D Beier Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription J Clin Invest 99 1997 1130 1137